Skip to main content

Table 2 Univariate and Multivariate survival analysis of patients before propensity-score match (N = 2587)

From: The long-term survival outcomes of gastric cancer patients with total intravenous anesthesia or inhalation anesthesia: a single-center retrospective cohort study

Characteristics

Univariate

Multivariate

HR

95% CI

P value

HR

95% CI

P value

Age, years

< 65 vs. ≥65

1.307

1.157–1.477

< 0.001

1.217

1.075–1.379

0.002

Gender

Male vs. Female

0.998

0.879–1.133

0.978

   

Tumor location

AEG vs. Non-AEG

0.723

0.638–0.819

< 0.001

0.882

0.777–1.002

0.054

Tumor size, cm

< 5 vs. ≥5

2.714

2.388–3.084

< 0.001

1.352

1.168–1.566

< 0.001

Macroscopic type

Type 0–2 vs. Type 3–4

2.080

1.850–2.338

< 0.001

1.164

1.026–1.321

0.019

Differentiate degree

G1–2 vs. G3

1.517

1.291–1.782

< 0.001

1.105

0.935–1.306

0.240

Radical degree

R0 vs. R1/R2

3.084

2.473–3.846

< 0.001

1.920

1.534–2.404

< 0.001

Lymphadenectomy degree

D1/D1+ vs. D2/D2+

1.035

0.869–1.232

0.701

   

pTNM stage

I vs. II

2.601

2.048–3.304

< 0.001

2.316

1.803–2.974

< 0.001

I vs. III

6.519

5.284–8.042

< 0.001

4.970

3.916–6.308

< 0.001

Adjuvant chemotherapy

No vs. Yes

0.884

0.786–0.995

0.041

0.715

0.634–0.807

< 0.001

Anesthesia method

IVA vs. IHA

1.054

0.881–1.262

0.566

0.932

0.778–1.116

0.441

NSAIDs

No vs. Yes

1.183

0.828–1.691

0.355

   
  1. Abbreviations: HR Hazard ratio, CI Confidence interval, AEG Adenocarcinoma of esophagogastric junction, TIVA Total intravenous anesthesia, IHA Inhalation anesthesia, NSAIDs Nonsteroidal Anti-inflammatory Drugs
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us